secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tvardi Therapeutics, Inc. (TVRD)
CIK:        0001346830
Form:       8-K
Filed at:   2024-03-22T23:59:59+00:00
Accession:  0001104659-24-037855
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Cara Therapeutics CMO Joana Goncalves resigns effective April 16, 2024
----------------------------------------------------------------------

- Dr. Joana Goncalves notified Company of resignation on March 19, 2024.
- Departure is to pursue another opportunity and not related to any disagreement.
- She will remain CMO through April 16, 2024, assisting in transition.
- Duties will be assumed by other senior management team members.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1346830/000110465924037855/0001104659-24-037855-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1346830/000110465924037855/tm249486d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-037855

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer